As the UAE celebrates its 54th Eid Al Etihad, I extend my warmest greetings to the leadership and the friendly people of this ...

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing ...

Q32 Bio Inc. ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced ...

Xeris Biopharma Holdings, Inc. , a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today ...

Tissue expansion, originally developed for super-resolution imaging, has become a foundation for expansion omics (ExO), a ...

The integration of nanotechnology with bioinspired materials is rapidly transforming the landscape of advanced healthcare solutions. Despite the remarkable ...

In the biotech field, alongside the widely recognized industry giants, some relatively smaller companies focused on specific niches are also demonstrating considerable potential through solid R& ...

Dallas is focusing on new and advanced treatments, like those that use cells or genes. They are also looking at how biology ...